在哥伦比亚玻利瓦尔的儿科侵入性肺炎球菌病:一个描述性的横截面研究
Wilfrido Coronell Rodríguez1, Andrés Felipe Mora-Salamanca2, José Santacruz-Arias2
1Universidad de Cartagena, Cartagena, Bolívar, Colombia.
Le infezioni in medicina
|December 11, 2024
概括
侵袭性肺炎球菌病 (IPD) 对哥伦比亚的弱势儿童产生重大影响,导致重症监护室的入院率和死亡率很高. 新兴的卡巴胺耐药性对儿科IPD病例越来越令人担忧.
科学领域:
- 儿童传染病 儿童传染病
- 临床微生物学 临床微生物学
- 公共卫生流行病学 流行病学
背景情况:
- 侵袭性肺炎球菌病 (IPD) 仍然是哥伦比亚儿童健康的一个重要问题,尽管存在疫苗接种计划.
- 了解儿童IPD的特征对于有针对性的公共卫生干预至关重要.
研究的目的:
- 描述儿科IPD病例的社会人口统计,流行病学和临床特征.
- 为了确定在哥伦比亚的玻利瓦尔市普遍存在的 *Streptococcus pneumoniae* (Spn) 血清型和抗菌素耐药性模式.
主要方法:
- 进行了一项描述性的横截面研究,分析了2016年至2023年的儿科IPD病例.
- 数据是从医疗记录中追溯收集的,包括来自哥伦比亚国家卫生研究院的SPN血型鉴定.
- 使用描述性统计数据来分析患者的特征和结果.
主要成果:
- 确定了54例儿科IPD病例,主要是来自低社会经济背景的2-9岁儿童.
- 最常见的血清型是Spn19A (20.4%). 抗微生物药物耐药性显示出万科米辛的敏感性,但34%的人的梅罗胺敏感性下降.
- 儿童重症监护室 (PICU) 住院率高 (79.6%) 和死亡率高 (35.2%),住院时间中位数为13.5天.
结论:
- IPD不成比例地影响了哥伦比亚玻利瓦尔的弱势儿童,导致严重的临床结果.
- 高的PICU入院率和死亡率强调了改善预防和治疗策略的必要性.
- 在 *Streptococcus pneumoniae* 隔离物中出现碳烯耐药性的出现是一个关键问题,需要进一步监测.
相关概念视频
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pneumonia III: Complications and Assessment
165
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
165
Pneumonia I: Introduction
211
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
Pneumonia V: Nursing management and Prevention
1.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
Pneumonia II: Pathophysiology
216
The pathophysiology of pneumonia involves the following steps:
216
Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299


